Nathan Handler, DO
Hospitalist · Des Moines, IANPI 1437641537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson accounts for 62.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $188 and has fallen 90.1% since, to $19 in 2021.
Across 21 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$189
- AbbVie$37
- Novo Nordisk$31
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
- Boehringer Ingelheim$15
- Boston Scientific$12
What the payments were for
- Food & beverage$303100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $189 |
| AbbVie | 2 | $37 |
| Novo Nordisk | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
| Boston Scientific | 1 | $12 |
How this compares
$303 in reported general payments places this provider in the 85th percentile of 223 hospitalist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $306 |
| Pantoprazole Sodium | 17 | $245 |
| Carvedilol | 11 | $208 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $163 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Des Moines
- Ala MustafaDes Moines$7K
- Gregory BerryDes Moines$4K
- Daniel KandahDes Moines$1K
- Jason WangDes Moines$774
- Guadalupe OsorioDes Moines$693
- Ho DangDes Moines$651
- Joshua LlorenteDes Moines$562
- Christopher StancicDes Moines$482
- Cecilia MolloyDes Moines$482
- Trivian NguyenDes Moines$477
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.